In contrast, a report from Australia showed that the 8 EP300-ZNF384 patients had favorable outcomes compared with other 85 BCP-ALL patients, and they explained that half of these patients were transplanted might be one reason (8). This evidence concerns the gene ZNF384 and acute lymphoblastic leukemia.